News | May 01, 2025
Sigachi Industries signs MoU with Respilon Group
This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.
This partnership marks a significant milestone in Sigachi's strategy to expand into advanced drug delivery technologies.
Pregabalin Gel 8% is a novel topical solution for diabetic neuropathic pain
The new office in New Delhi marks a significant funding in the APAC region and reinforces the company’s commitment to advancing respiratory care in India
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
The Emcure Research Centre (ERC) will drive research across multiple dosage forms, including OSD, injectables, novel drug delivery systems (NDDS), inhalers and topical and transdermal formulations
According to IQVIA, the European market for Buprenorphine-based opioid dependency treatments in 2023 surpassed USD 355 million annually
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards
CPHI & PMEC India Expo 2024 to bring over 50,000 industry professionals and 2,000 exhibitors under one roof
Subscribe To Our Newsletter & Stay Updated
